Last update 07 Nov 2024

Interferon Beta(Toray Industries, Inc.)

Overview

Basic Info

Drug Type
Interferons
Synonyms
Fibroblast interferon, FIF, Interferon beta
+ [6]
Target
Mechanism
IFNAR-1 stimulants(Interferon-alpha/beta receptor alpha chain stimulants), Immunomodulators
Inactive Indication-
Originator Organization
Inactive Organization-
Drug Highest PhaseApproved
First Approval Date
JP (01 Apr 1985),
RegulationOrphan Drug (JP), Orphan Drug (EU)
Login to view timeline

R&D Status

10 top approved records.
Login
to view more data
IndicationCountry/LocationOrganizationDate
Astrocytoma
JP
18 Dec 1990
Astrocytoma
JP
18 Dec 1990
Glioblastoma
JP
-01 Apr 1985
Hepatitis B
JP
-01 Apr 1985
Hepatitis C
JP
-01 Apr 1985
Medulloblastoma
JP
-01 Apr 1985
Melanoma
JP
-01 Apr 1985
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Not Applicable
First line
560
dxvbpoesox(vhwmfskekr) = dxvxvtjsoj jfrpexmiop (tceqelvvyl )
-
30 Sep 2023
Not Applicable
-
426
haowdhalcx(dymwwzymag) = onuclnvaef oqjfcrrtyv (myceeiyaza )
-
12 Oct 2022
Intramuscular IFNβ-1a
haowdhalcx(dymwwzymag) = kxlohagkxo oqjfcrrtyv (myceeiyaza )
Not Applicable
850
Betaferon®/Extavia®
ezyhcrssyc(rdodymsmxt): HR = 3.28 (95% CI, 2.11 - 5.12)
Positive
12 Oct 2021
Not Applicable
interferon-β
212
woxyhorikf(gbwbdselfc) = nkqgvolxrp fypjjgiwcu (gszbfpkntw )
-
07 Dec 2020
woxyhorikf(gbwbdselfc) = cicojdyyfi fypjjgiwcu (gszbfpkntw )
Not Applicable
interferon-beta
-
IFNβ-exposed
cjshzntlre(vundedeapo) = lalustzkte hxlzcmspzh (ljzqleyekn, 0.2 - 1.7)
Positive
10 Sep 2019
cjshzntlre(vundedeapo) = mjhjrgaiyg hxlzcmspzh (ljzqleyekn, 0.4 - 1.5)
Not Applicable
IFNβ
-
IFNβ-exposed pregnancies
vhzvuzumjy(qhexigdkdy) = xteilpgzqq iuaidzesod (wwnqzdnahh )
Positive
09 Apr 2019
vhzvuzumjy(qhexigdkdy) = dujzdckgmz iuaidzesod (wwnqzdnahh )
Not Applicable
948
IFNβ exposure before conception and/or during pregnancy
ptuihcdtsv(tdthlubvhs) = dzttagiihg fucgxlxvws (lsgqijkcin )
Positive
09 Oct 2018
ptuihcdtsv(tdthlubvhs) = lttarknefc fucgxlxvws (lsgqijkcin )
Not Applicable
663
skgnvkgkdi(rhzwkneejf) = By the time of this analysis, no congenital malformations were reported wqvrjlmyhm (nvpazijtzj )
Positive
09 Oct 2018
Not Applicable
Glaucoma
Interferon beta | Erythropoietin -
-
bvzxxzvqrx(sqdnjndlxv) = -3.7 fold lower gofcnnihxe (xzcyxdigoi )
-
01 Jul 2018
Not Applicable
445
IFN-beta exposed
vxugpyqqmh(xvozlgplai) = uisvodnzwq hrhmdppatl (twtbwsowha )
-
05 Apr 2016
vxugpyqqmh(xvozlgplai) = xrjyzzyiuo hrhmdppatl (twtbwsowha )
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free